Advertisement

Peter Hanson, IPS' Director of Process Architecture, Asia and EMEA talks about changes in biopharmaceutical design for facilities in these emerging markets including shifts in investments and the types of investments. Companies today are shifting away from large facilities and are looking for cost-effective and flexible facility solutions. In addition they are looking at maximizing the use of closed systems, implementing disposable technologies, using smaller footprints and implementing lean and just-in-time strategies.

Advertisement
Advertisement